glp 1 drugs for alcohol use disorder GLP-1 RAs may reduce alcohol-related hospitalization risk UW studying whether GLP-1 drugs,

Arterioscler Thromb Vasc Biol 2013;33:22522260

MAUD-Obesity Trial (n = 3,276): Alcohol-related hospitalization occurred in 10.2% of newer GLP-1 RA users and 28.5% of MAUD users

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout References McMurray, J

New prescriptions for these drugs have doubled among people who have obesity but not diabetes, investigators found

In PCOS-related trials, even with low starting doses and gradual titration, discontinuation rates of approximately 5%15% are frequently observed (125, 128)